E Rosen, A Rubowitz, J R Ferencz. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Angiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabChoroid Diseases/complicationsChoroidal Neovascularization/drug therapyFemaleHumansPhotosensitizing Agents/therapeutic usePorphyrins/therapeutic usePregnancyPregnancy Complications/drug therapyVerteporfin
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedPhotosensitizing AgentsPorphyrinsVerteporfinBevacizumab
Year: 2008 PMID: 18617903 DOI: 10.1038/eye.2008.218
Source DB: PubMed Journal: Eye (Lond) ISSN: 0950-222X Impact factor: 3.775